HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-beta-carbolines.

Abstract
'Bended' 1, 3 or 'linear' 2 pyrrolidino-fused (aza)carbazoles were prepared and screened towards a few cancer-related targets. Whereas 'bended' derivatives 1 and 3 proved to be weakly toxic, several members of the 'linear' family strongly interact with DNA, especially derivative 28a.
AuthorsM Laronze, M Boisbrun, S Léonce, B Pfeiffer, P Renard, O Lozach, L Meijer, A Lansiaux, C Bailly, J Sapi, J-Y Laronze
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 13 Issue 6 Pg. 2263-83 (Mar 15 2005) ISSN: 0968-0896 [Print] England
PMID15830466 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Carbazoles
  • Carbolines
  • Enzyme Inhibitors
  • Indoles
  • Pyrroles
  • Topoisomerase I Inhibitors
  • indole
  • DNA
  • Glycogen Synthase Kinase 3 beta
  • CDC2 Protein Kinase
  • Glycogen Synthase Kinase 3
  • glycogen synthase kinase 3 alpha
  • DNA Topoisomerases, Type I
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology, toxicity)
  • CDC2 Protein Kinase (antagonists & inhibitors, metabolism)
  • Carbazoles (chemical synthesis, chemistry, pharmacology, toxicity)
  • Carbolines (chemical synthesis, chemistry, pharmacology, toxicity)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • DNA (genetics, metabolism)
  • DNA Footprinting
  • DNA Topoisomerases, Type I (metabolism)
  • Enzyme Inhibitors (chemical synthesis, chemistry, pharmacology, toxicity)
  • Glycogen Synthase Kinase 3 (antagonists & inhibitors, metabolism)
  • Glycogen Synthase Kinase 3 beta
  • Indoles (chemistry)
  • Inhibitory Concentration 50
  • Mice
  • Molecular Structure
  • Nucleic Acid Denaturation
  • Pyrroles (chemistry)
  • Structure-Activity Relationship
  • Temperature
  • Titrimetry
  • Topoisomerase I Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: